Filters

Experiments

Compound Investigated event Experiment type Concentration Cell line Organism Animal model Stat protein Details
FLL32 Influence on protein activity Western Blot 8.00 µM Hs294T Homo sapiens
FLL32 Influence on protein activity Western Blot 2.00 µM A375 Homo sapiens
FLL32 Influence on protein activity Western Blot 4.00 µM A375 Homo sapiens
FLL32 Influence on protein activity Western Blot 6.00 µM A375 Homo sapiens
FLL32 Influence on protein activity Western Blot 8.00 µM A375 Homo sapiens
FLL32 Influence on protein activity Western Blot 2.00 µM Hs294T Homo sapiens
FLL32 Influence on protein activity Western Blot 4.00 µM Hs294T Homo sapiens
FLL32 Influence on protein activity Western Blot 6.00 µM Hs294T Homo sapiens
FLL32 Influence on protein activity Western Blot 8.00 µM Hs294T Homo sapiens
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1 p-STAT3
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1 p-STAT3
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1 p-STAT3
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1 p-STAT3
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2 p-STAT3
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2 p-STAT3
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2 p-STAT3
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2 p-STAT3
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1 STAT3
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1 STAT3
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1 STAT3
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1 STAT3
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2 STAT3
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2 STAT3
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2 STAT3
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2 STAT3
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 1
FLL32 Influence on apoptosis Western Blot 2.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 4.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 6.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on apoptosis Western Blot 8.00 µM primary human cells derived from recurrent cutaneous melanoma tumors Homo sapiens patient 2
FLL32 Influence on protein binding to DNA EMSA 2.00 µM STAT3